$500 million! That's the savings Sandoz has provided in just two years to the US healthcare system as a result of the successful adoption of one of our oncology supportive care biosimilar into clinical practice. Sandoz has eight biosimilar approved globally including four in the US and more than ten in the pipe line. Biosimilar may enable more patients to access advanced

Participate in, coordinate and/or lead projects, including those with cross team and/or cross divisional scope. This position can be located at any of the U.S. offices (Cambridge, MA; East Hanover, NJ; La Jolla, CA or Emeryville, CA). This position will require about 5% travel as defined by the business (domestic and/ or international). EEO Statement The Novartis Group of

5,600 people dedicated to discovery across 6 research locations around the globe! The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. We collaborate across scientific and organizational boundaries, with a focus on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients. Join our glob

500 million. The number of patients reached through our work. Our Purpose at Sandoz is to pioneer access for patients. By delivering on our Purpose day to day, we contribute to society's ability to support growing healthcare needs. The Associate Director, US Bio Supply Launch Project Management is responsible for project management and execution for all supply launch acti

The pay range for this position at commencement of employment is expected to be between PCP Sales Specialist $66,000 and $99,000/year | Senior PCP Sales Specialist $84,000 and $126,000/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pa

Bringing life changing medicines to millions of people, Novartis sits at the intersection of cutting edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of pro grams & an in house marke

Of the nearly 300K patients in the US diagnosed with complement driven renal diseases (CDRD), 25% 50% will progress to end stage kidney disease (ESKD) within a decade of diagnosis. These patients with IgA Nephropathy (IgAN), C3 Glomerulopathy (C3G), atypical Hemolytic Uremic Syndrome (aHUS), and Membranous Nephropathy (MN) are often young, and the impacts of the diseases

The pay range for this position at commencement of employment is expected to be between Cardiovascular Sales Specialist $97,600 and $146,400/year | Senior Cardiovascular Sales Specialist $118,400 and $177,600/year | Executive Cardiovascular Sales Specialist $130,400 and $195,600/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, fluctuations in

The pay range for this position at commencement of employment is expected to be between Cardiovascular Sales Specialist $97,600 and $146,400/year | Senior Cardiovascular Sales Specialist $118,400 and $177,600/year | Executive Cardiovascular Sales Specialist $130,400 and $195,600/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, fluctuations in

The pay range for this position at commencement of employment is expected to be between Cardiovascular Sales Specialist $97,600 and $146,400/year | Senior Cardiovascular Sales Specialist $118,400 and $177,600/year | Executive Cardiovascular Sales Specialist $130,400 and $195,600/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, fluctuations in

180+. The number of dedicated and inspired legal associates around the world supporting all aspects of the Sandoz business. Our US IP litigation docket is poised to grow by 50% in 2023 and will double in 2024. We are looking for an experienced, intellectually curious litigator to join our team and drive Sandoz's transformational growth journey. Join us and make an impact

2023! That's when Sandoz will become a standalone organization! As a global market leader in Generics and Biosimilar medicine, Sandoz is stepping forward from a position of strength! Those joining Sandoz in the coming months will help shape the future of the company, its growth, innovation, culture and how Sandoz impacts the lives of millions. Embark on a career with genu

Bringing life changing medicines to millions of people, Novartis sits at the intersection of cutting edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs, and an in house mar

Millions. Bringing life changing medicines to millions of people, Novartis sits at the intersection of cutting edge medical science and innovative digital technology. The Associate Director of Legal Innovation and Operations will be primarily responsible for managing Novartis's external and internal legal supplier relationships, including (1) building and maintaining trus

$500 million! That's the savings Sandoz has provided in just two years to the US healthcare system as a result of the successful adoption of one of our oncology supportive care biosimilar into clinical practice. Sandoz has eight biosimilar approved globally including four in the US and more than ten in the pipeline. Biosimilar may enable more patients to access advanced b